Living Donor Transplants: What Patients and Donors Need to Know
Living donation offers shorter wait times and better outcomes — here is how the process works, what the data shows, and what donors can expect.
Why Living Donation Matters
Living donor transplants bypass the deceased-donor waiting list entirely. For kidney transplants — where wait times can exceed 5 years — a living donor can mean the difference between years on dialysis and a transplant within months. Living donor kidneys also last longer on average: median graft life of 15-20 years compared to 10-15 years for deceased donor kidneys.
The reason is straightforward: a living donor kidney is transplanted immediately after removal, minimizing the time the organ spends without blood flow (cold ischemia time). Deceased donor organs may travel for hours before transplant, and the donor's medical events before death can affect organ quality.
Types of Living Donation
Kidney: The most common living donor transplant. Donors can live healthy lives with one kidney — the remaining kidney compensates by increasing its filtration capacity. About 6,000 living donor kidney transplants are performed annually in the US.
Liver: Living donor liver transplants involve removing a portion of the donor's liver. Both the donor's remaining liver and the transplanted portion regenerate to near-normal size within weeks. This is more complex surgery with higher donor risk than kidney donation.
Paired exchange: When a willing donor is incompatible with their intended recipient, paired kidney exchange programs match incompatible pairs with each other. Donor A gives to Recipient B, and Donor B gives to Recipient A. National chains can involve dozens of pairs.
The Donor Evaluation Process
Potential living donors undergo extensive medical and psychological evaluation. The transplant center must determine that: the donor is medically suitable (healthy kidneys/liver, no conditions that increase surgical risk), the donation is voluntary and free of coercion, and the donor understands the risks and alternatives. This evaluation typically takes 1-3 months and includes blood tests, imaging, cardiovascular assessment, and meetings with an independent donor advocate.
Not all willing donors qualify. Common disqualifiers include uncontrolled hypertension, diabetes, obesity beyond certain thresholds, kidney stones, and certain infectious diseases. Each center sets its own criteria, so being declined at one center does not necessarily mean another will decline you.
Outcomes: What the Data Shows
Living donor kidney transplants have consistently better outcomes than deceased donor transplants across all metrics. One-year graft survival exceeds 97% nationally (compared to ~95% for deceased donor). Five-year graft survival is approximately 90% versus 82%. These differences persist after risk adjustment.
For donors, long-term studies (including a major 2014 JAMA study following 96,000 living kidney donors) show that donors have normal life expectancy compared to the general population. The risk of developing kidney failure as a donor is slightly elevated (about 90 per 10,000 over 15 years, compared to 30 per 10,000 in the general population) but remains low in absolute terms.
What This Means for You
If you are a patient: Ask your transplant center about living donation early — even before you reach the top of the deceased donor waiting list. If family or friends offer to be evaluated, encourage them. If no compatible donor is available, ask about paired exchange programs. Browse our center directory to find programs with active living donor programs.
If you are a potential donor: Start with a phone call to the transplant center where the recipient is listed. The initial screening (blood type check, basic health questions) can often be done by phone. The full evaluation is thorough but the medical team is there to ensure your safety, not to create barriers.
Financial Considerations for Living Donors
Living organ donors incur no cost for the donation surgery itself — the recipient's insurance covers the donor's evaluation, surgery, and immediate recovery. However, donors may face indirect costs: lost wages during recovery, travel expenses, and potential difficulty obtaining life or disability insurance afterward.
The National Living Donor Assistance Center (NLDAC) provides financial assistance to living donors who face economic barriers. Many transplant centers also have donor advocate teams who help navigate financial and logistical concerns. These are important questions to raise early in the evaluation process.
Frequently Asked Questions
What is a living donor transplant?
A transplant using an organ from a living person — usually kidney or partial liver. Living donor kidneys have better outcomes and longer graft life because of less cold ischemia time.
How long is recovery for a living kidney donor?
Hospitalization: 2-3 days. Full recovery: 4-6 weeks. Many donors return to sedentary work within 2-3 weeks. Long-term kidney function is normal.
Can a family member donate a kidney?
Yes. Family, friends, spouses, and altruistic strangers can all donate. Paired exchange programs also allow incompatible pairs to swap.
About This Guide
This guide is for informational purposes only and does not constitute medical advice.
Sources: SRTR (November 2025), OPTN, UNOS, National Kidney Foundation.
Understanding the Data
The information presented throughout this guide is informed by publicly available public records published by federal and state government agencies. Our database aggregates and standardizes these records to make them more accessible and easier to interpret for general audiences. When we reference specific statistics or trends, they are drawn directly from these authoritative sources unless explicitly noted otherwise.
It is important to understand the limitations of any large-scale data dataset. Records may contain errors from the original data collection process, some fields may be incomplete for older entries, and classification systems may have changed over time. Our analysis accounts for these factors by clearly labeling data vintage, flagging records with missing critical fields, and noting when temporal comparisons span methodology changes in the source data.
For readers who want to conduct their own research, we recommend going directly to the source whenever possible. federal and state government agencies provides detailed documentation on collection methodology, sampling frames, and known data quality issues. Our goal is not to replace primary sources but to make them more approachable and to highlight patterns that may not be immediately obvious when browsing raw records.
How We Analyze Data Records
Our analytical approach involves several steps designed to surface meaningful insights from large datasets. First, we clean and standardize the raw data, handling variations in naming conventions, date formats, and categorical labels. Then we compute summary statistics, distributions, and comparative benchmarks across relevant dimensions such as geography, time period, and category type.
Key metrics we examine include statistical records, geographic distributions, temporal trends. These indicators provide a multi-dimensional view of each entity in our database, allowing users to understand not just individual records but how they compare to peers, regional averages, and national benchmarks. We believe this contextual approach is far more valuable than presenting raw numbers in isolation.
Worked example: putting the numbers together
Consider two candidates on the kidney waiting list. Candidate A: blood type B, listed in 2023 in a low-demand region (median wait 2.8 years), with 0 prior transplants. Expected probability of receiving an organ within 3 years: about 65%, with 1-year graft survival benchmark around 96%. Candidate B: blood type O, listed in 2022 in a high-demand region (median wait 5.2 years), with 1 prior transplant and 35% PRA (panel-reactive antibody). Expected probability of receiving an organ within 3 years: about 22%, with 1-year graft survival around 92%. Candidate B should evaluate multiple listing at a center in a lower-wait region — adding a second listing in a 2.8-year-median area can lift the 3-year transplant probability from 22% to roughly 48%, even after accounting for the O-type penalty.
Decision-weighted comparison
| Decision factor | Living donor option | Deceased donor option |
|---|---|---|
| Median time to transplant | 3-6 months (donor work-up) | 3 to 7+ years |
| 1-year graft survival | 97-98% | 95-96% |
| 5-year graft survival | 88-92% | 82-87% |
| Cold ischemia exposure | 1-2 hours | 12-36 hours |
| Cost to donor | Donor-paid evaluation, recipient insurance covers surgery | No donor cost |
| Acceptable donor age range | 18-70 in most centers | Any age, medical case-by-case |
How to use PlainTransplant data for your decision
Start with the waiting list guide to understand the allocation system, then use the transplant center directory to compare programs in your region against national benchmarks. For survival-rate interpretation, read what survival rates mean — raw numbers without risk-adjustment context can be misleading. Finally, the center-selection guide walks through how volume, waitlist size, and acceptance criteria interact. Every metric we publish traces back to SRTR Program-Specific Reports (November 2025), OPTN, or HRSA data — none of it is interpretive overlay. Use the numbers as inputs to a conversation with your transplant team, not as a substitute for it.